BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2898576)

  • 1. Anticatatonic effect of venoruton.
    Aley KO; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The action of neuroleptics on different types of catalepsy in rats with a genetic predisposition to catatonic reactions].
    Kolpakov VG; Nikulina EM; Alekhina TA; Gevorgian MM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1995; 45(2):388-94. PubMed ID: 7597835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
    Gábor M
    Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
    [No Abstract]   [Full Text] [Related]  

  • 4. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
    ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
    Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of venoruton on hypoxic stress-induced neurotoxicity in mice and oxygen free radical generation by human neutrophils.
    Shukla VK; Sethi AK; Garg SK; Ganguly NK; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1989; 299():127-33. PubMed ID: 2774763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venoruton as a radioprotector: a haematological assessment.
    Kanwar KC; Shukla VK; Verma A
    Radiobiol Radiother (Berl); 1990; 31(6):517-22. PubMed ID: 2101456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
    Dobbins DE; Soika CY; Dabney JM
    Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
    Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
    Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of 0-(beta-hydroxyethyl)-rutin on the oedema-inhibiting effect of indomethacin.
    Blazsó G; Gábor M
    Acta Pharm Hung; 1994 Jul; 64(4):123-4. PubMed ID: 7976365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Venoruton on the factor XIII activity in rat plasma.
    Grochal M; Sempińska-Edelberg E; Plewiński J
    Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats.
    Shukla VK; Garg SK; Mathur VS; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):236-48. PubMed ID: 3938209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticatatonic effect of clonidine: its interaction with dopaminergic, anticholinergic and GABA-ergic drugs.
    Shukla VK; Garg SK; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):33-43. PubMed ID: 3021074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venoruton in the therapy of central retinal vein occlusion.
    Zygulska-Mach H; Kostka-Trabka E; Kielar J; Grodzinska L; Dieron K; Kedzior A
    Ther Hung; 1985; 33(2):79-82. PubMed ID: 3842005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
    Artaria LG
    Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effects of O-(beta-hydroxyethyl)-rutosides (HR) against adriamycin-induced toxicity in rats.
    Gulati OP; Nordmann H; Aellig A; Maignan MF; McGinness J
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):323-34. PubMed ID: 4004421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
    Belcaro G; Rulo A; Candiani C
    Vasa; 1989; 18(2):146-51. PubMed ID: 2662674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the hematological profile in rat following whole body gamma radiation with and without venoruton pretreatment.
    Kanwar KC; Verma A
    J Environ Pathol Toxicol Oncol; 1992; 11(4):235-9. PubMed ID: 1507075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-edema activity of injectable Venoruton in abdominal surgery].
    De Anna D; Liboni A; Paoli M; Pollinzi V; Malin L; Mannella P; Ambroso G; Oberhauser V
    Minerva Chir; 1979 Oct; 34(20):1377-92. PubMed ID: 503345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat.
    Dobyan DC; Bull JM; Strebel FR; Sunderland BA; Bulger RE
    Lab Invest; 1986 Nov; 55(5):557-63. PubMed ID: 3773477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.